Notably, as a crucial protein negatively regulating the G protein signaling pathway, RGS5 is highly expressed in perivascular cells of diverse tumor tissues and is crucial in angiogenesis and vascular remodeling during cancer progression, and it reduces the efficacy of tumor radiotherapy, chemotherapy, and immunotherapy [34,35]. Here, RGS5 is linked to neoplasm.